IRIS
DURANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.016
EU - Europa 9.393
AS - Asia 5.731
SA - Sud America 493
AF - Africa 71
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 10
Totale 29.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.851
CN - Cina 2.774
GB - Regno Unito 2.614
IT - Italia 1.964
SG - Singapore 1.619
UA - Ucraina 1.375
SE - Svezia 709
RU - Federazione Russa 677
FI - Finlandia 553
TR - Turchia 499
DE - Germania 465
BR - Brasile 373
FR - Francia 351
IE - Irlanda 332
VN - Vietnam 315
IN - India 142
CA - Canada 103
PL - Polonia 84
NL - Olanda 72
JP - Giappone 61
KR - Corea 57
HK - Hong Kong 54
ES - Italia 43
AR - Argentina 40
MX - Messico 39
BD - Bangladesh 37
AU - Australia 29
AT - Austria 27
BE - Belgio 26
IQ - Iraq 26
ZA - Sudafrica 26
ID - Indonesia 22
CL - Cile 19
IR - Iran 14
CO - Colombia 13
AE - Emirati Arabi Uniti 12
PK - Pakistan 12
EC - Ecuador 11
LT - Lituania 11
SA - Arabia Saudita 11
CH - Svizzera 10
PE - Perù 10
UZ - Uzbekistan 10
VE - Venezuela 10
MA - Marocco 9
HR - Croazia 8
HU - Ungheria 8
JO - Giordania 8
PY - Paraguay 8
RO - Romania 8
EU - Europa 7
LV - Lettonia 7
MY - Malesia 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
GR - Grecia 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
EG - Egitto 5
SM - San Marino 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
KG - Kirghizistan 4
UY - Uruguay 4
AM - Armenia 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LU - Lussemburgo 3
NG - Nigeria 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
HN - Honduras 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
Totale 29.726
Salva come PNG Salva come JPEG
Città #
Southend 2.316
Woodbridge 1.678
Ann Arbor 1.244
Houston 1.124
Jacksonville 1.090
Ashburn 1.056
Fairfield 1.052
Chandler 894
Singapore 856
San Jose 690
Nanjing 557
Cambridge 476
Dallas 470
Wilmington 449
Seattle 435
Beijing 408
Izmir 345
Dublin 271
Boardman 257
Urbino 249
Helsinki 236
Nanchang 192
San Mateo 169
Lauterbourg 165
New York 163
Princeton 161
Los Angeles 123
Hebei 118
Shenyang 118
Changsha 98
Jiaxing 97
Ho Chi Minh City 96
Istanbul 92
Council Bluffs 91
Tianjin 87
Velikiy Novgorod 82
Santa Clara 68
Düsseldorf 67
Hanoi 66
Rome 63
Milan 60
Munich 59
Kunming 57
Buffalo 53
San Francisco 53
Hong Kong 52
Seongnam 52
Menlo Park 48
Moscow 48
San Diego 47
São Paulo 47
Toronto 47
Dong Ket 46
London 46
Bremen 43
Shanghai 42
Nuremberg 38
Guangzhou 35
Warsaw 35
Frankfurt am Main 34
Hangzhou 34
Stockholm 34
Jinan 33
Chicago 32
Mülheim 32
Des Moines 31
Kraków 30
Changchun 28
Denver 28
Tokyo 28
Orem 27
Brussels 24
Chennai 24
Montreal 24
Mumbai 24
Ningbo 23
Lanzhou 22
Manchester 20
The Dalles 20
Ancona 19
Brooklyn 19
Napoli 19
Palermo 19
Amsterdam 18
Dearborn 18
Norwalk 18
Zhengzhou 18
Haikou 17
Leawood 17
Taizhou 17
Hefei 16
Johannesburg 16
Mexico City 16
Pesaro 16
Shenzhen 16
Ankara 15
Cava De' Tirreni 15
Florence 15
Haiphong 15
Naples 15
Totale 20.083
Salva come PNG Salva come JPEG
Nome #
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 865
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 444
Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity 411
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 369
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 350
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 285
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis, Binding Affinity for Melatonin Receptor, and Evaluation of the Biological Activity 281
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 281
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 277
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 276
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 275
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 268
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 261
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus 261
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 259
Lactose oleate as new biocompatible surfactant for pharmaceutical applications 255
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 251
Synthesis, Structure-Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers 250
A combination of sugar esters and chitosan to promote in vivo wound care 248
2-Bromomelatonin: Synthesis and characterization of a potent melatonin agonist 243
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 242
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 242
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents 242
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 240
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines 234
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 233
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 232
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 230
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 227
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 226
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 223
An endocannabinoid mechanism for stress-induced analgesia 219
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 214
Peripherally Restricted FAAH Inhibitors 214
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 213
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 211
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 211
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 211
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 209
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis and Binding Affinity to the Melatonin Receptor 206
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 204
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 203
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 202
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 202
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 201
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 201
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 200
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 198
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 195
Modulation of anxiety through blockade of anandamide hydrolysis 193
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 192
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 191
Antimyotonic effects of enantiomers of mexiletine-like drugs 191
Therapeutic Effects of Tocainide and Mexiletine Analogs on Myotonic MTO and ADR Mice 190
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 189
Derivato tetramerico ciclico dell’indol-3-carbinolo CTet come chemiopreventivo in tumori al seno estrogeno-dipendenti 188
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 188
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 187
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 185
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 185
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 185
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 185
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 184
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition 184
SYNTHESIS AND EVALUATION OF SUGAR-BASED ALIPHATIC AND AROMATIC FATTY ACID ESTERS AS ANTIMICROBIAL AND ANTIBIOFILM AGENTS 183
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 182
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 181
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 179
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 178
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 178
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 177
Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels 176
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 175
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 175
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 171
Identification of a Bioactive Impurity Present in a Sample of URB754 171
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 170
Analoghi chirali della mexiletina: attività sui canali ionici 164
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 163
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 158
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 157
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 157
Contribution to the Study of 2-Aryloxy-1-phenyl and 2-Aryloxy-2-phenylethanols. Differentiation by Mass Spectrometry 155
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 154
2,6-Xilididi e β-2,6-xililossietilammine come ligandi anfipatici per i recettori benzodiazepinici di tipo mitocondriale 154
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 153
Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418) 152
Inhibitors of lysosomal lipid amidase NAAA 151
Relationships Between Mass Spectrometry and Biological Stability of Some N-Acylethanolamine Acid Amidase Inhibitors 151
Anestetici locali (Cap. 14) 150
Antinoceptive Effects of the N-Acylethanolamine Acid Amidase Inhibitor ARN077 in Rodent Pain Models 149
Chronic stimulation of the endogenous anandamide tone reduces cocaine-seeking and cue-induced relapse in rats 148
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 146
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 145
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 144
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 142
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 142
FAAH and MGL Inhibitors. Design and Therapeutic Implications 142
Structure Activity Relationships (SARs) and mechanism of action of a potent class of N-acylethanolamine acid amidase (NAAA) inhibitors 139
Synthesis and Biological Evaluation of 6-O-Sucrose Monoester Glycolipids as Possible New Antifungal Agents 139
Totale 21.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021865 0 0 0 0 0 0 0 0 0 320 386 159
2021/20221.758 89 219 205 183 71 41 83 97 121 99 47 503
2022/20232.761 312 129 65 357 215 574 42 241 467 93 149 117
2023/2024781 96 54 56 91 54 166 37 49 15 66 28 69
2024/20252.662 139 140 619 204 97 192 296 152 244 160 237 182
2025/20266.037 538 724 779 1.069 508 457 868 264 446 384 0 0
Totale 30.017